Clinical Trials Arena

6 articles in the TruthFoundry index. Each links out to the original.

• Life Science Manufacturers Shift to Digital Compliance to Avoid Penalties · Life science manufacturers must transition to digital frameworks to mitigate regulatory risks and data integrity failures.
• Novo Nordisk halts two Phase III ziltivekimab trials after failures · Novo Nordisk ends HERMES and ATHENA trials for ziltivekimab due to data monitoring committee recommendations.
• Clover Biopharmaceuticals Respiratory Vaccines Win Phase II Trial in Elderly · Clover Biopharmaceuticals reports positive Phase II data for its dual and triple respiratory virus vaccine candidates in older adults.
• Acepodia Secures FDA Clearance for Phase I ACE723 Trial · Acepodia receives FDA clearance to start a Phase I trial for its GPC3-targeting antibody-drug conjugate ACE723.
• Novartis Pelacarsen Fails Primary Endpoint in Lp(a)HORIZON Cardiovascular Trial · Novartis reports pelacarsen failed to reduce cardiovascular risk in the Lp(a)HORIZON Phase III trial.
• IQVIA Framework for Choosing Qualified vs. Advanced Electronic Signatures in Global Trials · IQVIA outlines a four-dimension framework for selecting qualified or advanced electronic signatures in clinical trials.